Endometrial Safety Study

• Status: Completed
• Trial end date: 2009-08-01

Summary

The study is designed to investigate the safety of the investigational product for the lining of the uterus (endometrium).

• Phase: Phase 3

Details

• Lead Sponsor: Bayer
• Collaborators: Diagnostic Cytology Laboratory; Laboratorium für Klinische Forschung; University of California, San Francisco
• Treatments: Drospirenone; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Norethindrone; Norethindrone acetate; Polyestradiol phosphate